APA (7th ed.) Citation

DR, L., T, O., S, M., H, Z., M, K., JA, T., . . . CM, L. (2026). Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity. Cancer immunology research. https://doi.org/10.1158/2326-6066.CIR-25-0794

Chicago Style (17th ed.) Citation

DR, Lu, et al. "Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways That Potentiate and Limit Antitumor Immunity." Cancer Immunology Research 2026. https://doi.org/10.1158/2326-6066.CIR-25-0794.

MLA (9th ed.) Citation

DR, Lu, et al. "Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways That Potentiate and Limit Antitumor Immunity." Cancer Immunology Research, 2026, https://doi.org/10.1158/2326-6066.CIR-25-0794.